WALTHAM, Mass., May 13, 2015 (GLOBE NEWSWIRE) — AMAG Pharmaceuticals, Inc. (Nasdaq:AMAG) today announced that William Heiden, AMAG’s chief executive officer, will present at the UBS Global Healthcare Conference on Monday, May 18, 2015 at 3:00 p.m. ET in New York. The session will include a company presentation followed by a question and answer session, in which the company’s financial results, business update, and growth prospects will be discussed.
A live audio webcast of the discussions will be accessible through the Investors section of the company’s website at www.amagpharma.com. Following the conference, the webcast will be archived on the AMAG Pharmaceuticals, Inc. website for 30 days.
AMAG Pharmaceuticals, Inc. is a specialty pharmaceutical company with a focus on maternal health, anemia and cancer supportive care. The primary goal of AMAG is to bring to market therapies that provide clear benefits and improve patients’ lives. In addition to continuing to pursue opportunities to make new advancements in patients’ health and to enhance treatment accessibility, AMAG intends to continue to expand and diversify its portfolio through the in-license or purchase of additional pharmaceutical products or companies. For additional company information, please visit www.amagpharma.com.
CONTACT: AMAG Pharmaceuticals, Inc. Contact:
Vice President, Investor Relations & Corporate Communications
AMAG Pharmaceuticals, Inc.